Standout Papers

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients 2014 2026 2018 2022 399
  1. TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients (2014)
    Rafael Bejar, Allegra M. Lord et al. Blood

Immediate Impact

2 by Nobel laureates 10 from Science/Nature 65 standout
Sub-graph 1 of 22

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Transient loss of Polycomb components induces an epigenetic cancer fate
2024 StandoutNature
2 intermediate papers

Works of Michal Bar‐Natan being referenced

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
2014 Standout
The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
2011

Author Peers

Author Last Decade Papers Cites
Michal Bar‐Natan 705 358 509 40 1.3k
Pascale Lepelley 730 290 369 51 1.2k
Nicholas Lea 816 505 675 36 1.5k
Juan Li 656 289 591 62 1.2k
Barbara Czepulkowski 728 245 372 45 1.3k
R Schirò 552 311 349 35 1.2k
Anuj Mahindra 896 225 691 55 1.2k
Bertil Uggla 585 191 476 31 1.1k
Marcus M. Schittenhelm 754 352 597 42 1.5k
Carlos Bueso-Ramos 1031 557 734 35 1.7k
F. Dreyfus 636 321 459 54 1.2k

All Works

Loading papers...

Rankless by CCL
2026